Objective(s) Oscillometric blood pressure (BP) measurement devices frequently replace the standard mercury sphygmomanometer. Comparisons of oscillometric devices are rare, but their agreement is important to ensure comparability of BP data. This study aims to compare two oscillometric devices, Datascope Accutorr Plus and Omron HEM-705CP II, and to develop BP conversion models.
Introduction
Hypertension is a widespread risk factor for cardiovascular diseases and a major determinant of mortality and morbidity [1, 2] . Estimates of hypertension prevalence and incidence are important for decisions in health policy and prevention and therefore accurate blood pressure (BP) measurement is a prerequisite for many interventions.
During the past few years, the oscillometric BP measurement technique has increasingly replaced the auscultatory mercury sphygmomanometry in epidemiological studies [3, 4] and has also been used in clinical trials and long-outcome studies [5] [6] [7] . Although the mercury sphygmomanometer continues to be the gold standard for BP measurement, it is frequently replaced by oscillometric devices because of the toxicity of mercury [8] and observer bias [9] , which are frequent with the auscultatory technique. Validation of new oscillometric BP devices is obtained through comparison with the gold standard mercury sphygmomanometer and accuracy is evaluated on the basis of criteria specified in protocols of international societies, that is, the European Society of Hypertension International Protocol revision 2010 for the validation of BP measuring devices (ESH-IP2) and the protocols of the British Hypertension Society (BHS) and the American Association for the Advancement of Medical Instrumentation (AAMI) [10] [11] [12] .
However, passing these validation protocol criteria still allows for considerable disagreement between devices. For example, to pass the AAMI criteria for systolic blood pressure (SBP) and diastolic blood pressure (DBP), mean differences between measurement pairs should be 5 mmHg or less with a SD of 8 mmHg or less, whereas for BHS grade A validation, the absolute difference between measurement pairs should be within 5 mmHg in at least 60% of measurement pairs, within 10 mmHg in at least 85%, and within 15 mmHg in at least 95%. The ESH-IP2 additionally requires an individual-based analysis of agreement and specifies criteria on the basis of the frequencies of pairs 5 mmHg or less and at least 15 mmHg for every individual. The results of many validation studies are summarized on a website (http:// www.dableducational.org). Most importantly, as oscillometric devices operate with their own model-specific algorithms to calculate BP values and as the manufacturer-provided cuffs and cuff selection instructions also differ, measurement agreement between oscillometric devices that were successfully validated against the mercury sphygmomanometer gold standard cannot be taken for granted.
The present study addresses this issue by comparing two oscillometric devices: the Datascope Accutorr Plus and the Omron HEM-705CP II. The Datascope Accutorr Plus is a device designed for professional use and is used in two representative health surveys in Germany, the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) and the German Health Interview and Examination Survey for Adults (DEGS1) [13, 14] , as well as other health surveys [15, 16] , whereas the Omron device, which is designed for professional as well as home BP measurement, is used by several regional German epidemiological studies with a focus on cardiovascular epidemiology [17] [18] [19] . Both devices yielded favorable results in several validation studies compared with the mercury sphygmomanometer gold standard [20] [21] [22] [23] [24] [25] , but have not been compared with each other before.
Methods
This methodological study compared two oscillometric devices: the Datascope Accutorr Plus (Accutorr Plus; Datascope Corp., Mahwah, New Jersey, USA) and the Omron HEM-705CP II (Omron Healthcare UK Ltd, Milton Keynes, UK).
A sample of 109 adults aged 21-64 years (70 women, 39 men) was recruited at a scientific institute with mainly white-collar workers. Informed consent and assent were obtained from all participants. Individuals with arrhythmia or a pacemaker (ascertained by personal interview and pulse palpation) were excluded from the study [10] . The study was approved by the Ethical Committee of Charité University Medicine Berlin and by the German Federal Commissioner for Data Protection and Freedom of Information.
The comparison of Datascope and Omron was performed in a sequence of serial same-arm BP measurements alternating the devices and their manufacturer-provided cuffs. The study design followed the principles outlined in the ESH-IP2 [10] . At the same time, the study protocol closely followed the protocols of the DEGS1, which used the Datascope Accutorr Plus, and the protocol of a regional epidemiologic study with a focus on cardiovascular diseases, the Kooperative Gesundheitsforschung in der Region Augsburg study (KORA-2000), which has served as a model for several subsequent cardiovascular cohort studies in Germany [4, 17, 18] .
These study protocols are in line with the standardization instructions of the ESH-IP2, but as the manufacturer's instructions for the selection of individual cuffs for a given arm circumference (AC) overlapped slightly (e.g. instructions allowed the use of the small and also the medium cuff for AC, 28.0 cm), this overlap was removed following the DEGS1 and KORA-2000 protocols to make instructions unequivocal.
A standardized measurement environment was created in a quiet study room. The participants sat and relaxed for at least 5 min on a height-adjustable chair, their back supported. The elbow was slightly bent and lying on a table at the level of the right atrium. Both feet were straight on the floor and legs were not crossed. Manufacturer-provided cuffs were used for each device. The correct cuff size was identified by measuring the upper AC between the acromion and the olecranon.
For the Datascope Accutorr Plus, three different cuffs were available with a bladder size of 10.6 Â 23.9 cm for ACs ranging from 21.0 to 27.9 cm (manufacturer instruction: 20.5-28.5 cm), a bladder size of 13.5 A Datascope Accutorr Plus and an Omron HEM-705CP II device with a set of manufacturer-provided cuffs were selected randomly from the study equipment of DEGS1 and KORA-2000. Both devices provide BP readings to the nearest 1 mmHg and were checked for technical correctness by the German Federal Institute of Science and Technology.
Nine sequential same-arm BP measurements were performed in each participant starting with the Datascope device. The first measurement with each device was not used for analysis. Measurements were at least 30 s apart to avoid venous congestion, but not more than 60 s to avoid increased variability.
The analysis was based on BP measurement pairs. Each Omron measurement was compared with the nearer of the previous and next Datascope measurement. The Datascope measurement that was closest to the Omron measurement was used to define a measurement pair.
The device differences in SBP and DBP were calculated as Omron minus Datascope, and the cuff width to arm circumference ratio (CW/AC-R) and the cuff length to arm circumference ratio (CL/AC-R) were computed for both devices. and hypertensive BP 140/90 mmHg or more [1]. Pulse pressure was calculated as SBP minus DBP for both devices. The mean and SD of device differences was ascertained and stratified by sex, age, BP categories, AC groups, cuff sizes, tertiles of CW/AC-R, and CL/AC-R as well as the differences in CW/AC-R and CL/AC-R of the devices (r 0 and >0%) and Wilcoxon signed-rank tests were performed to check for the significance of measurement differences. The frequencies of SBP and DBP differences within 5, 10, 15, and more than 15 mmHg were calculated and the differences were plotted against the average BP values of both devices (Bland-Altman plots). The prevalence of hypertensive BP values was determined for both devices and Cohen's k was calculated to assess agreement of allocation to hypertension status. Prediction of Datascope SBP and DBP on the basis of Omron and vice versa was attempted through linear regression analysis. The variables included initially were the value of SBP or DBP of the corresponding device, sex, age, AC, pulse pressure and, as they were highly correlated, the cuff sizes, the CW/AC-R, the CL/AC-R, and the differences in CW/AC-R and CL/AC-R were each at a time included separately. Starting from these four full models, all nonsignificant variables were excluded in a stepwise order until only the significant factors (P < 0.05) remained. IBM SPSS Statistics (version 20; SPSS Inc., Chicago, Illinois, USA) was used for analyses.
Results
A total of 109 participants completed the study, resulting in 327 BP measurement pairs for analyses. The basic characteristics of the study population are summarized in Table 1. The mean difference in Omron-SBP minus Datascope-SBP was 2.5±5.7 and 0.7±3.5 mmHg for DBP (P < 0.05), respectively. Moreover, the SBP difference was larger in men than in women (4.0±6.1 vs. 1.7±5.3 mmHg; P < 0.05) and increased with age (from 2.4±4.7 mmHg for age group <40 years to 4.7±8.0 mmHg for >60 years; P < 0.05). Moreover, SBP disagreement was particularly high for hypertensive BP (BP Z 140 mmHg, mean difference±SD 9.3±6.7 mmHg; P < 0.05) ( Fig. 1 ) and in the highest Omron pulse pressure tertile (pulse pressure > 50 mmHg, mean difference±SD 5.6±6.3 mmHg; P < 0.05). The pattern of differences for DBP was similar. Men had a slightly higher mean difference and the difference decreased with age, but these findings were not significant. Again, the DBP difference increased significantly with DBP, but only a few measurements were within the hypertensive range (Fig. 2) . The CW/AC-R of Omron was higher in 96.3% of participants, meaning that the Omron cuff was larger in relation to AC than the corresponding Datascope cuff. For the few cases in whom the Omron cuff was smaller (resulting in a CW/AC-R difference < 0), the measurement disagreement in SBP and particularly in DBP was high [CW/AC-R < 0: SBP difference 3.0±3.7 mmHg (P < 0.05) and 4.1±4.3 mmHg for DBP (P < 0.05), respectively] (Table 2) . Plot of systolic blood pressure differences between Omron HEM-705CP II and Datascope Accutorr Plus against the mean of the two devices in 109 participants (n = 327).
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SBP differences were within ±5 mmHg in 66% of measurement pairs, within ±10 mmHg in 91%, and were less than 15 mmHg in 98% (for DBP 89, 99, and 100%) ( Table 2) .
Hypertension prevalence by device
The prevalence of hypertensive BP on the basis of Omron measurements was noticeably higher as opposed to Datascope (11 vs. 5%). From 110 measurement pairs that were classified as prehypertensive with Datascope, 21% were labeled hypertensive with Omron, whereas only 3% were categorized as hypertensive with Datascope, but were prehypertensive according to Omron. Cohen's k amounted to 0.67 (P < 0.05) (data not shown).
Conversion of systolic blood pressure and diastolic blood pressure from Omron HEM-705CP II into Datascope Accutorr Plus and vice versa
The models for the conversion models of BP values from one device to the other were developed through linear regression analysis. Parameter selection was performed on the basis of previous studies on factors influencing oscillometric measurements [26] [27] [28] [29] . In addition, various variables reflecting cuff sizes and cuff selection rules were considered as manufacturer-provided cuffs as well as cuff selection rules were not equivalent for the two devices and could have influenced the measurements [30] [31] [32] [33] [34] [35] [36] . The final models containing only the significant factors are shown in Table 3 and these can be used for equations to convert BP values from Datascope into Omron and vice versa before comparisons of BP data are performed. For example, the comparability of BP data gathered within the specified German studies could be enhanced by applying these conversion formulas.
Discussion
This study compares two frequently used upper arm oscillometric BP devices, Datascope Accutorr Plus and Omron HEM-705CP II, which had both previously shown good agreement with gold standard mercury sphygmomanometer measurements according to international validation protocols [20] [21] [22] [23] [24] [25] . When directly comparing Datascope Accutorr Plus and Omron HEM-705CP II measurements in this study, the agreement of DBP remained good (mean difference 0.7±3.5 mmHg), but the mean SBP difference was 2.5±5.7 mmHg and higher in participants with elevated SBP, leading to a higher estimate of hypertension prevalence when BP was measured with Omron as compared with Datascope (11 vs. 5%). The formulas for the conversion of BP values from one device to the other include BP, pulse pressure, sex, age, AC, and the difference in CW/AC-R.
Both devices passed validation protocols of international societies, that is, the Datascope device was validated according to the protocols of the AAMI and BHS [20] [21] [22] and Omron was further evaluated according to the ESH criteria [23] [24] [25] . In comparison with the mercury sphygmomanometer, Datascope Accutorr Plus SBP was on average almost identical in two studies in adults and slightly lower in children (device-observer difference 0.0±7.9 mmHg [20] ; 0.1±7.5 mmHg [21] ; and -0.9±4.3 mmHg [22] ). Datascope DBP was lower in these three studies compared with the auscultatory method with a mercury sphygmomanometer (device-observer difference -0.4±5.8 mmHg [20] ; -2.5± 5.2 mmHg [21] ; and -1.3±6.5 mmHg [22] ). For the specific Omron model HEM-705CP II, no validation studies are available, but three validations were performed for the model Omron 705IT, which was declared equivalent [37] .
The Omron 705IT SBP was on average slightly higher than mercury sphygmomanometer readings by 0.6± 6.0 mmHg in one validation study in adults [23] and slightly lower by 0.2±4.5 mmHg in a second validation study in adults [24] . In children, the Omron 705IT SBP was higher by 4.0±4.8 mmHg [25] . Moreover, another Omron 705IT equivalent, the Omron M6 upper arm device (HEM-7001-E), was validated separately and consistently slightly overestimated SBP by B1 mmHg. DBP, however, was underestimated by this Omron device in a similar magnitude (around 1 mmHg) in all the groups studied (adults, obese adults, elderly) [38] [39] [40] .
In addition, the predecessor model Omron HEM-705CP was evaluated in validation studies and furthermore in studies with modifications of the formal validation protocols (e.g. in terms of measurement procedure, cuff selection, or patient/BP requirements). Again, SBP was mostly overestimated and DBP was predominantly underestimated [41] [42] [43] [44] [45] [46] . However, it is not clear whether any alterations in the measurement algorithm were Plot of diastolic blood pressure differences between Omron HEM-705CP II and Datascope Accutorr Plus against the mean of the two devices in 109 participants (n = 327).
performed between the Omron HEM-705CP and its successor HEM-705CP II that could have had an effect on the measurements. Hence, the results of these studies may not be transferable.
Thus, although both oscillometric devices passed international validations, underestimation of SBP by one device and overestimation by the other device may result in a surprising difference if the devices are compared with one another. Second, validation studies often used the same cuffs for the auscultatory and oscillometric mea-surements, but in our study, the manufacturer-provided cuffs were applied, which differ in size and ratios of cuff width and cuff length to AC. Last but not the least, although both devices are based on the oscillometric technique, manufacturers develop their own algorithms to calculate SBP and DBP from pulse oscillations in the cuff. For this reason, some measurement disagreement between oscillometric devices is likely [47] .
Not all validation studies for Datascope and Omron report on the device performance at different BP levels. Similar to other studies, we observed an increasing device disagreement with increasing SBP in this study [41, 44, 48] . For Datascope, two studies found an increasing disagreement with the gold standard mercury sphygmomanometer at SBP extremes (> 190 mmHg) [20, 21] , whereas for Omron SBP measurement difference increased at higher SBP in one study, but agreement was similarly good within all BP ranges in another study [23, 24] .
For DBP, all three validation studies with Datascope found a similarly good agreement over the entire DBP range, whereas the Omron 705IT as well as the Omron M6 showed either an increasing disagreement at low [24, 38] or at high [23, 25, 39] BP levels. Moreover, one study with the M6 found that with increasing BP, a disagreement of more than 10 mmHg was more prevalent in a group with obese adults, but not in the group with normal adults [40] .
However, for many oscillometric devices, the measurement differences increase with increasing BP and a study comparing six electronic devices with a mercury sphygmomanometer showed that for four out of six devices, accuracy decreased in the highest pressure category (> 160/100 mmHg) [48] .
Sex, age, and AC were also associated with device differences. Men had a higher SBP and DBP mean difference than women and the SBP difference increased with age for both sexes, whereas for DBP, the difference decreased nonsignificantly with age. However, this observation is limited by the small sample size in the oldest age group. Sex-related differences have also been reported elsewhere [18, 26, 49] . The effect of age on oscillometric BP measurement accuracy was often subject to investigation and is influenced by alterations in the viscoelastic structure of the arterial wall and the pulse pressure amplitude, that is, the increase in arterial stiffness but also other factors that are associated with age (e.g. soft arm tissue, CW/AC-R, atrial fibrillation, or heart rate) [50, 51] .
The different cuff sizes were associated with discrepancies in BP. For the majority of individuals, the Omron cuff was larger in relation to the AC than the corresponding Datascope cuff, reflected in a CW/AC-R difference more than 0%. Consequently, overcuffing because of a cuff size that is too large for a given AC [32, 35] was more likely with the Omron device. In fact, the measurement disagreement was smaller if the Omron cuff was larger and especially the DBP difference was high within the few cases, where the Omron cuff was smaller than the Datascope cuff. Notably, overcuffing with Omron probably leads to an underestimation of BP. For this reason, the measurement disagreement could be even higher with better-fitting Omron cuffs.
Finally, the accuracy of oscillometric measurement is also affected by arterial stiffness [26, 29, 51, 52] . Arterial stiffness may lead to broader plateaus and more complex shapes of the oscillometric BP waveform [27, 51, 53] and may differentially influence oscillometric BP values calculated on the basis of device-specific algorithms. Indeed, the exact way of calculating SBP and DBP is proprietary and one cannot discern how a specific device model operates in the presence of arterial stiffness. We used pulse pressure as an indicator for arterial stiffness because it tends to increase with stiffer arteries. The measurement difference in SBP increased with pulse pressure but the DBP difference, although not significant, decreased. Two other studies have reported similar results. One study found a strong correlation of SBP discrepancy with pulse pressure in patients with persistent unreliable oscillometric BP readings (device difference > 10 mmHg in at least two clinic visits of a particular individual) and there was a consistent trend for larger SBP differences across pulse pressure quintiles. Similar to our study, the differences in DBP decreased along pulse pressure quintiles [26] . In the other study, an oscillometric Dinamap device overestimated SBP in patients with pulse pressures of 60 mmHg or more (SBP difference 3.47±11.15 mmHg), whereas in general, SBP was slightly underestimated (-0.52±9.84 mmHg) [54] . The magnitude of DBP difference was smaller in individuals with pulse pressure of 60 mmHg or more compared with the overall sample.
Moreover, two more studies support an effect of arterial stiffness on oscillometric BP measurement accuracy. Arterial stiffness was measured with carotid-femoral pulse wave velocity in one study and an increasing overestimation of SBP and DBP, obtained with a Dinamap device in comparison with a random-zero sphygmomanometer, was found with increasing arterial stiffness [29] . The other study observed a more severe overestimation of SBP in a group of insulin-dependent diabetics, known to have stiffer arteries, but a less severe underestimation of DBP in comparison with a mercury sphygmomanometer [55] .
A strength of this study is the relatively large sample size, which exceeded the requirements set out in validation protocols (i.e. 85 participants), and the well-balanced sample with respect to sex, age, and BP distribution. Furthermore, the study design and standardization were compliant with the specifications of the ESH-IP2. Another positive finding was the large degree of explained variability. Accordingly, the conversion models operate well with just a few and easily available variables included.
However, the difficulties in recruiting participants with high BP, especially high DBP, represent a limitation of our study. The defined BP range of the ESH-IP2 was not fulfilled and the conversion models may be less robust in the hypertensive BP range.
However, the range close to the hypertension threshold (135-145/85-95 mmHg) is sufficiently reflected in our sample. Moreover, our results are not generalizable to children and adolescents as individuals younger than 18 years of age were not included and also individuals with arrhythmia or a pacemaker were excluded and thus the device performance for these groups remains unclear.
Last but not the least, the possible implications of our results are of interest. We found a mean systolic measurement difference exceeding 2 mmHg, which is of a magnitude that is relevant at the population level. It has been estimated that 2-3 mmHg lower mean population SBP could reduce mortality from coronary heart disease by 4-5% and stroke mortality could be even more reduced by 6-8% [56] .
Furthermore, in our study, the prevalence of hypertension measured with the Omron device was twice as high as with Datascope. This large difference may be because of the fact that many individuals have BP levels that are only marginally above or below the hypertension threshold. However, SBP measurements differed by more than 10 mmHg in more than one-third of those above the hypertension threshold and in 20% of the elderly as well as of those in the highest tertile of pulse pressure. Such larger differences may result in differential treatment decisions, suggesting that differences between oscillometric devices may be of particular clinical relevance in specific patient groups, such as geriatric patients or patients with diabetes and end-stage renal disease [28, 53, 55, [57] [58] [59] .
In summary, our study suggests that BP values from different oscillometric devices may differ more than suggested by validation studies because of three reasons: (i) underestimation by one device and overestimation by the other device may add up, (ii) manufacturer-provided cuffs may differ and lead to cuff-related BP measurement differences, and (iii) validation studies evaluate only overall agreement over a wide range of BPs and may mask more pronounced disagreement, for example, for measurements around and above hypertension threshold or measurements in patients with increased pulse pressure such as patients with diabetes or more generally in the elderly. This implies caution in the clinical care context when comparing measurements performed with different devices. In clinical as well as epidemiological studies, cuff sizes and cuff selection rules should always be reported.
